New Agonist- and Antagonist-based Treatment Approaches for Advanced Prostate Cancer

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.4, 2012-07, pp. : 1217-1226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 290-302

Bentham Science Publishers

Access to resources Recommend Favorite

The Treatment of Advanced Prostate Cancer with Ketoconazole: Safety Issues

By Bok R.A. Small E.J.

Drug Safety, Vol. 20, Iss. 5, 1999-05 ,pp. : 451-458

Adis International

Access to resources Recommend Favorite

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

By Mongiat-Artus Pierre Teillac Pierre

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2171-2179

Informa Healthcare

Access to resources Recommend Favorite

New Discoveries in Prostate Cancer Biology and Treatment

By Cooper Carlton R Chay Christopher H Pienta Kenneth J

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 123-127

Informa Healthcare

Access to resources Recommend Favorite

New Features in the Treatment of Androgen-Independent Prostate Cancer

Current Pharmaceutical Design, Vol. 10, Iss. 5, 2004-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite